Theravance Biopharma TBPH reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Theravance Biopharma beat estimated earnings by 45.45%, reporting an EPS of $-0.18 versus an estimate of $-0.33.
Revenue was up $3.79 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 5.2% increase in the share price the next day.
Here's a look at Theravance Biopharma's past performance:
|Quarter||Q3 2021||Q2 2021||Q1 2021||Q4 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.